These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

213 related articles for article (PubMed ID: 26002136)

  • 1. Intrahepatic mass-forming cholangiocarcinoma: prognostic value of preoperative gadoxetic acid-enhanced MRI.
    Koh J; Chung YE; Nahm JH; Kim HY; Kim KS; Park YN; Kim MJ; Choi JY
    Eur Radiol; 2016 Feb; 26(2):407-16. PubMed ID: 26002136
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Differentiation of intrahepatic mass-forming cholangiocarcinoma from hepatocellular carcinoma on gadoxetic acid-enhanced liver MR imaging.
    Kim R; Lee JM; Shin CI; Lee ES; Yoon JH; Joo I; Kim SH; Hwang I; Han JK; Choi BI
    Eur Radiol; 2016 Jun; 26(6):1808-17. PubMed ID: 26373763
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Intrahepatic mass-forming cholangiocarcinoma: enhancement patterns on gadoxetic acid-enhanced MR images.
    Kang Y; Lee JM; Kim SH; Han JK; Choi BI
    Radiology; 2012 Sep; 264(3):751-60. PubMed ID: 22798225
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Diagnostic accuracy of liver imaging reporting and data system (LI-RADS) v2014 for intrahepatic mass-forming cholangiocarcinomas in patients with chronic liver disease on gadoxetic acid-enhanced MRI.
    Joo I; Lee JM; Lee SM; Lee JS; Park JY; Han JK
    J Magn Reson Imaging; 2016 Nov; 44(5):1330-1338. PubMed ID: 27087012
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Differentiating combined hepatocellular and cholangiocarcinoma from mass-forming intrahepatic cholangiocarcinoma using gadoxetic acid-enhanced MRI.
    Hwang J; Kim YK; Park MJ; Lee MH; Kim SH; Lee WJ; Rhim HC
    J Magn Reson Imaging; 2012 Oct; 36(4):881-9. PubMed ID: 22730271
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Imaging features of intrahepatic cholangiocarcinoma in Gd-EOB-DTPA-enhanced MRI.
    Péporté AR; Sommer WH; Nikolaou K; Reiser MF; Zech CJ
    Eur J Radiol; 2013 Mar; 82(3):e101-6. PubMed ID: 23159401
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Identification of Imaging Predictors Discriminating Different Primary Liver Tumours in Patients with Chronic Liver Disease on Gadoxetic Acid-enhanced MRI: a Classification Tree Analysis.
    Park HJ; Jang KM; Kang TW; Song KD; Kim SH; Kim YK; Cha DI; Kim J; Goo J
    Eur Radiol; 2016 Sep; 26(9):3102-11. PubMed ID: 26634931
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Gadoxetic acid enhanced magnetic resonance imaging for prediction of the postoperative prognosis of intrahepatic mass-forming cholangiocarcinoma.
    Kim S; An C; Han K; Kim MJ
    Abdom Radiol (NY); 2019 Jan; 44(1):110-121. PubMed ID: 30078083
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Differentiation between inflammatory myofibroblastic tumor and cholangiocarcinoma manifesting as target appearance on gadoxetic acid-enhanced MRI.
    Chang AI; Kim YK; Min JH; Lee J; Kim H; Lee SJ
    Abdom Radiol (NY); 2019 Apr; 44(4):1395-1406. PubMed ID: 30515535
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Intrahepatic Mass-Forming Cholangiocarcinoma: Is There Additional Prognostic Value in Using Gd-EOB Enhanced MRI?
    Halskov S; Krenzien F; Segger L; Geisel D; Hamm B; Pelzer U; Ihlow J; Schöning W; Auer TA; Fehrenbach U
    Cancers (Basel); 2024 Mar; 16(7):. PubMed ID: 38610992
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Differentiating mass-forming intrahepatic cholangiocarcinoma from atypical hepatocellular carcinoma using gadoxetic acid-enhanced MRI.
    Chong YS; Kim YK; Lee MW; Kim SH; Lee WJ; Rhim HC; Lee SJ
    Clin Radiol; 2012 Aug; 67(8):766-73. PubMed ID: 22425613
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Small intrahepatic mass-forming cholangiocarcinoma: target sign on diffusion-weighted imaging for differentiation from hepatocellular carcinoma.
    Park HJ; Kim YK; Park MJ; Lee WJ
    Abdom Imaging; 2013 Aug; 38(4):793-801. PubMed ID: 22829097
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Added value of smooth hypointense rim in the hepatobiliary phase of gadoxetic acid-enhanced MRI in identifying tumour capsule and diagnosing hepatocellular carcinoma.
    An C; Rhee H; Han K; Choi JY; Park YN; Park MS; Kim MJ; Park S
    Eur Radiol; 2017 Jun; 27(6):2610-2618. PubMed ID: 27770230
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Added value of ancillary imaging features for differentiating scirrhous hepatocellular carcinoma from intrahepatic cholangiocarcinoma on gadoxetic acid-enhanced MR imaging.
    Choi SY; Kim YK; Min JH; Kang TW; Jeong WK; Ahn S; Won H
    Eur Radiol; 2018 Jun; 28(6):2549-2560. PubMed ID: 29335868
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Intrahepatic mass-forming cholangiocarcinomas: enhancement patterns at multiphasic CT, with special emphasis on arterial enhancement pattern--correlation with clinicopathologic findings.
    Kim SA; Lee JM; Lee KB; Kim SH; Yoon SH; Han JK; Choi BI
    Radiology; 2011 Jul; 260(1):148-57. PubMed ID: 21474703
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Optimizing CT and MRI criteria for differentiating intrahepatic mass-forming cholangiocarcinoma and hepatocellular carcinoma.
    Wu H; Liang Y; Wang Z; Tan C; Yang R; Wei X; Jiang X
    Acta Radiol; 2023 Mar; 64(3):926-935. PubMed ID: 35898164
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Fat-suppressed dynamic and delayed gadolinium-enhanced volumetric interpolated breath-hold magnetic resonance imaging of cholangiocarcinoma.
    Leyendecker JR; Gakhal M; Elsayes KM; McDermott R; Narra VR; Brown JJ
    J Comput Assist Tomogr; 2008; 32(2):178-84. PubMed ID: 18379298
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Gadoxetic acid disodium-enhanced MR imaging of cholangiolocellular carcinoma of the liver: imaging characteristics and histopathological correlations.
    Haradome H; Unno T; Morisaka H; Toda Y; Kwee TC; Kondo H; Sano K; Ichikawa T; Kondo F; Sugitani M; Takayama T
    Eur Radiol; 2017 Nov; 27(11):4461-4471. PubMed ID: 28439650
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Combined arterial and delayed enhancement patterns of MRI assist in prognostic prediction for intrahepatic mass-forming cholangiocarcinoma (IMCC).
    Jin KP; Sheng RF; Yang C; Zeng MS
    Abdom Radiol (NY); 2022 Feb; 47(2):640-650. PubMed ID: 34820689
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Intrahepatic mass-forming cholangiocarcinoma: enhancement pattern on Gd-BOPTA-MRI with emphasis of hepatobiliary phase.
    Mamone G; Marrone G; Caruso S; Carollo V; Gentile G; Crino' F; Milazzo M; Luca A
    Abdom Imaging; 2015 Oct; 40(7):2313-22. PubMed ID: 25962708
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 11.